These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 11032332)

  • 1. Acylcarnitines in plasma and blood spots of patients with long-chain 3-hydroxyacyl-coenzyme A dehydrogenase defiency.
    Van Hove JL; Kahler SG; Feezor MD; Ramakrishna JP; Hart P; Treem WR; Shen JJ; Matern D; Millington DS
    J Inherit Metab Dis; 2000 Sep; 23(6):571-82. PubMed ID: 11032332
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Acylcarnitines in fibroblasts of patients with long-chain 3-hydroxyacyl-CoA dehydrogenase deficiency and other fatty acid oxidation disorders.
    Shen JJ; Matern D; Millington DS; Hillman S; Feezor MD; Bennett MJ; Qumsiyeh M; Kahler SG; Chen YT; Van Hove JL
    J Inherit Metab Dis; 2000 Feb; 23(1):27-44. PubMed ID: 10682306
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Quantitative measurement of total and free 3-hydroxy fatty acids in serum or plasma samples: short-chain 3-hydroxy fatty acids are not esterified.
    Jones PM; Burlina AB; Bennett MJ
    J Inherit Metab Dis; 2000 Nov; 23(7):745-50. PubMed ID: 11117435
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Changes in blood carnitine and acylcarnitine profiles of very long-chain acyl-CoA dehydrogenase-deficient mice subjected to stress.
    Spiekerkoetter U; Tokunaga C; Wendel U; Mayatepek E; Exil V; Duran M; Wijburg FA; Wanders RJ; Strauss AW
    Eur J Clin Invest; 2004 Mar; 34(3):191-6. PubMed ID: 15025677
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Differences between acylcarnitine profiles in plasma and bloodspots.
    de Sain-van der Velden MG; Diekman EF; Jans JJ; van der Ham M; Prinsen BH; Visser G; Verhoeven-Duif NM
    Mol Genet Metab; 2013; 110(1-2):116-21. PubMed ID: 23639448
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effect of fasting, long-chain triglyceride load and carnitine load on plasma long-chain acylcarnitine levels in mitochondrial very long-chain acyl-CoA dehydrogenase deficiency.
    Costa CG; Dorland L; de Almeida IT; Jakobs C; Duran M; Poll-The BT
    J Inherit Metab Dis; 1998 Jun; 21(4):391-9. PubMed ID: 9700596
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Optimal dietary therapy of long-chain 3-hydroxyacyl-CoA dehydrogenase deficiency.
    Gillingham MB; Connor WE; Matern D; Rinaldo P; Burlingame T; Meeuws K; Harding CO
    Mol Genet Metab; 2003 Jun; 79(2):114-23. PubMed ID: 12809642
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Measurement of free carnitine and acylcarnitines in plasma by HILIC-ESI-MS/MS without derivatization.
    Peng M; Liu L; Jiang M; Liang C; Zhao X; Cai Y; Sheng H; Ou Z; Luo H
    J Chromatogr B Analyt Technol Biomed Life Sci; 2013 Aug; 932():12-8. PubMed ID: 23816563
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Non-invasive test using palmitate in patients with suspected fatty acid oxidation defects: disease-specific acylcarnitine patterns can help to establish the diagnosis.
    Janzen N; Hofmann AD; Schmidt G; Das AM; Illsinger S
    Orphanet J Rare Dis; 2017 Dec; 12(1):187. PubMed ID: 29268767
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lack of correlation between fatty acid oxidation disorders and haemolysis, elevated liver enzymes, low platelets (HELLP) syndrome?
    Holub M; Bodamer OA; Item C; Mühl A; Pollak A; Stöckler-Ipsiroglu S
    Acta Paediatr; 2005 Jan; 94(1):48-52. PubMed ID: 15858960
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Blood carnitine profiling on tandem mass spectrometry in liver cirrhotic patients.
    Miyaaki H; Kobayashi H; Miuma S; Fukusima M; Sasaki R; Haraguchi M; Nakao K
    BMC Gastroenterol; 2020 Feb; 20(1):41. PubMed ID: 32075591
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Elevations of C14:1 and C14:2 Plasma Acylcarnitines in Fasted Children: A Diagnostic Dilemma.
    Burrage LC; Miller MJ; Wong LJ; Kennedy AD; Sutton VR; Sun Q; Elsea SH; Graham BH
    J Pediatr; 2016 Feb; 169():208-13.e2. PubMed ID: 26602010
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Quantitative analysis of plasma acylcarnitines using gas chromatography chemical ionization mass fragmentography.
    Costa CG; Struys EA; Bootsma A; ten Brink HJ; Dorland L; Tavares de Almeida I; Duran M; Jakobs C
    J Lipid Res; 1997 Jan; 38(1):173-82. PubMed ID: 9034211
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Arrhythmias and conduction defects as presenting symptoms of fatty acid oxidation disorders in children.
    Bonnet D; Martin D; Pascale De Lonlay ; Villain E; Jouvet P; Rabier D; Brivet M; Saudubray JM
    Circulation; 1999 Nov; 100(22):2248-53. PubMed ID: 10577999
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Increased acylcarnitine ratio indices in newborn screening for carnitine-acylcarnitine translocase deficiency shows increased sensitivity and reduced false-positivity.
    Shi C; Ao Z; Liu B; Xiao X; Gu X; Yang Q; Hao H; Cai Y; Li S
    Transl Pediatr; 2023 May; 12(5):871-881. PubMed ID: 37305732
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Metabolic control during exercise with and without medium-chain triglycerides (MCT) in children with long-chain 3-hydroxy acyl-CoA dehydrogenase (LCHAD) or trifunctional protein (TFP) deficiency.
    Gillingham MB; Scott B; Elliott D; Harding CO
    Mol Genet Metab; 2006; 89(1-2):58-63. PubMed ID: 16876451
    [TBL] [Abstract][Full Text] [Related]  

  • 17. What is the role of medium-chain triglycerides in the management of long-chain 3-hydroxyacyl-CoA dehydrogenase deficiency?
    Lund AM; Dixon MA; Vreken P; Leonard JV; Morris AA
    J Inherit Metab Dis; 2003; 26(4):353-60. PubMed ID: 12971423
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sources of error in determinations of carnitine and acylcarnitine in plasma.
    Fishlock RC; Bieber LL; Snoswell AM
    Clin Chem; 1984 Feb; 30(2):316-8. PubMed ID: 6692545
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Carnitine palmitoyltransferase 2: New insights on the substrate specificity and implications for acylcarnitine profiling.
    Violante S; Ijlst L; van Lenthe H; de Almeida IT; Wanders RJ; Ventura FV
    Biochim Biophys Acta; 2010 Sep; 1802(9):728-32. PubMed ID: 20538056
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Changes in pediatric plasma acylcarnitines upon fasting for refined interpretation of metabolic stress.
    van Rijt WJ; van der Ende RM; Volker-Touw CML; van Spronsen F; Derks TGJ; Heiner-Fokkema MR
    Mol Genet Metab; 2019 Aug; 127(4):327-335. PubMed ID: 31279622
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.